Updates in prostate and bladder cancer therapy
25 Jul 2016
Updates in prostate and bladder cancer therapy
Review of olaparib for ovarian cancer
Lung cancer immunotherapy
'Other' targets in lung cancer
Developments in gastrointestinal tumour treatment
Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists
Editor's Choice for July 2016
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
DNA repair and mutations as targets for personalised therapy
Glioblastoma heterogeneity in circulating tumour DNA
Obesity promotes pancreatic cancer progression and resistance